GenomicsbioRxivPreprint
Copy-number intratumor heterogeneity contributes to predict relapse in chemotherapy-naive stage II colon cancer
Sara Lahoz, Iván Archilla, Elena Asensio…·Jordi Camps
The paper identifies copy-number intratumor heterogeneity as a predictor of relapse in stage II colon cancer, improving risk prediction beyond clinicopathological markers.
2 citations